Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1995
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995EP0681588A1 Max-interacting proteins and related molecules and methods
11/15/1995EP0681585A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use
11/15/1995EP0681483A1 Compositions and methods for delivery of genetic material
11/15/1995EP0681480A1 Recognin vaccines
11/15/1995EP0681477A1 Genetic modification of neural stem cells
11/15/1995EP0681431A1 Production of human recombinant collagen in the milk of transgenic animals
11/15/1995EP0681427A1 Tomato spotted wilt virus
11/15/1995EP0618930A4 Monoclonal antibody to hiv-2 and uses thereof.
11/15/1995EP0527977B1 Nematode vaccine
11/15/1995EP0480949B1 Production of virus and purification of viral envelope proteins for vaccine use
11/15/1995EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment
11/15/1995EP0444186B1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
11/15/1995EP0431146B1 Radionuclide metal chelates for the radiolabeling of proteins
11/15/1995EP0420913B1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
11/15/1995CN1111910A Mammamodulin, a hormone-independent mammary tumor cells specific protein
11/15/1995CN1111909A Novel polypeptide and DNA coding for the same
11/15/1995CN1111640A Lipopeptide derivatives, a process for their preparation and their use
11/15/1995CN1030255C Ring groth hormone releasing factor (GRF), analogue and its process
11/14/1995US5466861 Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
11/14/1995US5466792 RI T-DNA Promoters
11/14/1995US5466785 Tissue-preferential promoters
11/14/1995US5466783 Human tissue factor inhibitor
11/14/1995US5466781 Process for purifying bacterially produced M-CSF
11/14/1995US5466672 Anticancer
11/14/1995US5466671 Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum
11/14/1995US5466669 Immunostimulatory agent
11/14/1995US5466668 Anticoagulants using nucleic acids
11/14/1995US5466666 Dissolving in propanol/1-/ and buffer; diluting with water; precipitation; disulfide bridges
11/14/1995US5466598 Deacetylcephalosporin C acetyltransferase from Acremonium chrysogenum
11/14/1995US5466597 Bacillus thuringiensis strains and their genes encoding insecticidal toxins
11/14/1995US5466593 DNA fragments and gene expression
11/14/1995US5466590 Constitutive expression of P450soy and ferredoxin-soy in Streptomyces
11/14/1995US5466589 Coated substrates employing oriented layers of mutant heme proteins and methods of making and using same
11/14/1995US5466585 Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
11/14/1995US5466584 Oxytocin receptor and DNA coding therefor
11/14/1995US5466377 Chromatography media and their uses
11/12/1995CA2139384A1 Cytokine regulated transcription factor
11/10/1995CA2148301A1 Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
11/09/1995WO1995030326A1 Neural receptor tyrosine kinase
11/09/1995WO1995030019A1 Feline immunodeficiency virus vaccine
11/09/1995WO1995030018A2 Recombinant poxviruses with foreign polynucleotides in essential regions
11/09/1995WO1995030016A1 Methods for peptide synthesis and purification
11/09/1995WO1995030015A2 Isolated epstein-barr virus bzlf2 proteins that bind mhc class ii beta chains
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030008A1 Density enhanced protein tyrosine phosphatases
11/09/1995WO1995030006A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof
11/09/1995WO1995030005A1 Genes regulating the response of zea mays to water deficit
11/09/1995WO1995030003A2 Morphogenic protein-specific cell surface receptors and uses therefor
11/09/1995WO1995030002A2 Enhancing the sensitivity of tumor cells to therapies
11/09/1995WO1995030001A2 Novel p-selectin ligand protein
11/09/1995WO1995029991A1 A novel vzv gene, mutant vzv and immunogenic compositions
11/09/1995WO1995029988A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
11/09/1995WO1995029987A1 Beta taipoxin as a cell growth factor and method
11/09/1995WO1995029986A1 Method for controlling metallophosphate precipitation in high cell density fermentations
11/09/1995WO1995029938A1 Antigen/antibody specificity exchanger
11/09/1995WO1995029937A1 A new 78 residue polypeptide (nk-lysine) and its use
11/09/1995WO1995029936A1 Methods for controlling t lymphocyte mediated immune responses
11/09/1995WO1995029935A1 Method for proliferating and differentiating b cells, and uses thereof
11/09/1995WO1995029934A1 Method of separating protective components of bordetella pertussis
11/09/1995WO1995029933A1 Modified milk growth factor
11/09/1995WO1995029703A1 Introduction of hiv-protective genes into cells by particle-mediated gene transfer
11/09/1995WO1995029700A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/09/1995WO1995029699A1 Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa
11/09/1995WO1995029698A1 Tumor-associated antigen peptides and their use in tumor diagnosis and therapy
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029695A1 Epitaxin, a cell motility factor
11/09/1995WO1995029694A1 Collagen hydrolysis accelerator
11/09/1995WO1995029693A1 Methods and compositions for modulating heterotypic e-cadherin interactions with t lymphocytes
11/09/1995WO1995029692A1 An advanced glycosylation endproduct-receptor, and diagnostic and therapeutic methods based thereon
11/09/1995WO1995029690A1 Biologically active peptides and methods of identifying the same
11/09/1995WO1995029686A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995WO1995029685A1 Activin antagonists as novel contraceptives
11/09/1995WO1995028166A3 Method for implanting encapsulated cells in a host
11/09/1995WO1995017678A3 Differentiation of htlv-i and htlv-ii using synthetic peptides
11/09/1995DE4415997A1 Neuer peptidischer Wirkstoff und dessen Herstellung New peptidic drug and its preparation
11/09/1995DE4415743A1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/09/1995DE4415516A1 Phosphorylation of peptide(s) at hydroxy side chain substits.
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2190597A1 Genes regulating the response of zea mays to water deficit
11/09/1995CA2189425A1 Methods for controlling t lymphocyte mediated immune responses
11/09/1995CA2189357A1 Beta taipoxin as a cell growth factor and method
11/09/1995CA2189045A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/09/1995CA2189032A1 Enhancing the sensitivity of tumor cells to therapies
11/09/1995CA2189005A1 Activin antagonists as novel contraceptives
11/09/1995CA2188648A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
11/09/1995CA2188647A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995CA2188424A1 Method of separating protective components of bordetella pertussis
11/09/1995CA2187902A1 Morphogenic protein-specific cell surface receptors and uses therefor
11/09/1995CA2186365A1 Neural receptor tyrosine kinase
11/09/1995CA2165413A1 Methods for peptide synthesis and purification
11/08/1995EP0681028A1 A gene expression vector using the gene expression regulating region of the ADP ribosylation factor
11/08/1995EP0681027A2 Plasmid vector and its use for the production of heterologous proteins
11/08/1995EP0681025A1 Novel cloning host organisms
11/08/1995EP0680990A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/08/1995EP0680973A1 Peptides, process to prepare them and their use
11/08/1995EP0680765A1 Vaccine for nontypable haemophilus influenzae strain
11/08/1995EP0680514A1 Nematode-resistant transgenic plants
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995EP0680512A1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
1 ... 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 ... 2916